摘要
中药注射剂是我国目前临床应用广泛的一类药品,随着我国药品监管机制和药品不良反应监测与评价制度的不断完善,中药注射剂的不良反应报告也日益增多。本文通过分析中药注射剂的特点及发展现状,从中药注射剂安全性评价角度提出相关风险因素和控制措施,从而为提高中药注射剂安全性提供技术支持。
Traditional Chinese Medicine Injection（TCMI） is widely used in China at present. With the improvement of the drug supervision and administration and the adverse drug reaction surveillance system in China, the number of ADR reports is increasing steadily. The author put forward to related risk factors and risk control measurements after analyzing the characteristics of the traditional Chinese medicine injection and current status of the development, to offer information on the technical supports for improvement of the safety of TCMI.
出处
《中国药物警戒》
2012年第2期89-92,共4页
Chinese Journal of Pharmacovigilance
关键词
中药注射剂
药物不良反应
安全性评价
风险管理
traditional Chinese medicine injection
adverse drug reaction
safety evaluation
risk management
